Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- Scientists discover how hair cells can help heal skin faster
- Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
- Stem Cells Prevent Heart Failure After Heart Attack
- We need to start thinking of AI as “normal”
- Anti-fibrotic effect of human amniotic fluid stem cells in biliary epithelial-mesenchymal transition of liver ductal organoid
- Stanford makes stem cell transplants safer without chemo
